Aztreonam and Urosepsis - a phase IV clinical study of FDA data

Summary:

Urosepsis is reported as a side effect among people who take Aztreonam (aztreonam), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Urosepsis when taking Aztreonam. It is created by eHealthMe based on reports of 3,048 people who have side effects when taking Aztreonam from the FDA, and is updated regularly.

What is Aztreonam?

Aztreonam has active ingredients of aztreonam. eHealthMe is studying from 3,054 Aztreonam users. Check the latest studies of Aztreonam.

What is Urosepsis?

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream) is found to be associated with 893 drugs and 920 conditions by eHealthMe. Check the latest studies of Urosepsis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

3,048 people reported to have side effects when taking Aztreonam.
Among them, 11 people (0.36%) have Urosepsis.

Among these 11 people:

How long have people been on Aztreonam when they have Urosepsis? *

What is the gender of people who have Urosepsis when taking Aztreonam? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Urosepsis when taking Aztreonam? *

What are other drugs people take besides Aztreonam? *

What are other side effects people have besides Urosepsis? *

Acute Kidney Failure: 4 people, 36.36%
Urinary Tract Infection: 3 people, 27.27%
Acute Hepatic Failure: 2 people, 18.18%
Septic Shock (shock due to blood infection): 2 people, 18.18%
Osteomyelitis Chronic (long lasting infection of bone marrow): 2 people, 18.18%
Pneumonia: 2 people, 18.18%
Chronic Kidney Disease: 2 people, 18.18%
Renal Impairment (severely reduced kidney function): 2 people, 18.18%
Renal Tubular Necrosis (death of kidney tubules): 2 people, 18.18%
Fever: 2 people, 18.18%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 9.09%
Pneumonia: 1 person, 9.09%
Pain: 1 person, 9.09%
Ovarian Cancer (cancer of ovary): 1 person, 9.09%
Nausea And Vomiting: 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Infection: 1 person, 9.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Aztreonam and have Urosepsis?

- Check whether Urosepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aztreonam:

Aztreonam (3,054 reports)

Urosepsis treatments and more:

Urosepsis (11,959 reports)

Browse all side effects of Aztreonam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urosepsis:

Urosepsis (893 drugs)

Browse all the conditions that are associated with Urosepsis:

Urosepsis (920 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam (the active ingredients of Aztreonam) and Aztreonam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.